Prospective cardiovascular events in patients with advanced thoracic cancer treated with immune checkpoint inhibitor.

Autor: Toublanc AC; Pulmonary Department, CIC1401, CHU Haut-Lévèque, Bordeaux, France. Electronic address: anne-claire.toublanc@chu-bordeaux.fr., Faure M; Heart failure unit, Cardiology Department, CHU Haut-Lévèque, Bordeaux, France., Verdy G; Medical Informatics and Archiving Unit, CHU Bordeaux, France., Rabeau A; Pulmonary Department, CHU Larrey, Toulouse, France., Houard V; Arterial hypertension unit, Cardiology Department, CHU Rangueil, Toulouse, France., Veillon R; Pulmonary Department, CIC1401, CHU Haut-Lévèque, Bordeaux, France., Bardel C; Pulmonary Department, CIC1401, CHU Haut-Lévèque, Bordeaux, France., Vergnenegre C; Pulmonary Department, CIC1401, CHU Haut-Lévèque, Bordeaux, France., Dos Santos P; Heart failure unit, Cardiology Department, CHU Haut-Lévèque, Bordeaux, France; Lyric Institute, Bordeaux University, Pessac, France; University Institute of cancer, INSERM UMR1037, Toulouse, France., Mazieres J; Pulmonary Department, CHU Larrey, Toulouse, France; Oncology Research Center CRCT, INSERM UMR1037, Toulouse, France., Zysman M; Pulmonary Department, CIC1401, CHU Haut-Lévèque, Bordeaux, France; Bordeaux University, INSERM U1045, Pessac, France.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Aug; Vol. 207, pp. 114191. Date of Electronic Publication: 2024 Jun 24.

A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer.

Autor: Faubry C; Pulmonary Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France., Faure M; Heart Failure Unit, Cardiology Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France., Toublanc AC; Pulmonary Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France., Veillon R; Pulmonary Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France., Lemaître AI; Heart Failure Unit, Cardiology Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France., Vergnenègre C; Pulmonary Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France., Cochet H; Department Cardiology, Lyric Institute, Fondation Bordeaux Université, Bordeaux, France.; Department Medicine, Universitaire Bordeaux, Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux, France.; Department of Cardiovascular Imaging, Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, France., Khan S; Bordeaux University, Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux Population Health Research Center, Bordeaux, France., Raherison C; Pulmonary Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France.; Bordeaux University, Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux Population Health Research Center, Bordeaux, France., Dos Santos P; Heart Failure Unit, Cardiology Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France.; Department Cardiology, Lyric Institute, Fondation Bordeaux Université, Bordeaux, France.; Department Medicine, Universitaire Bordeaux, Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux, France., Zysman M; Pulmonary Department, Centre Hospitalier Universitaire (CHU) Haut-Lévèque, Bordeaux, France.; Centre de Recherche Cardio-Thoracique, Universitaire Bordeaux, Institut National de la Santé et de la Recherche Médicale (INSERM), Bordeaux, France.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2022 Jun 06; Vol. 9, pp. 878211. Date of Electronic Publication: 2022 Jun 06 (Print Publication: 2022).